Show simple item record

dc.contributor.authorDALLI, JPen_US
dc.date.accessioned2016-11-01T08:58:38Z
dc.date.available2016-08-24en_US
dc.date.issued2016-08-24en_US
dc.date.submitted2016-10-21T12:39:40.241Z
dc.identifier.issn1946-6242en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/16182
dc.description.sponsorshipThis work was supported by Fondazione Italiana Sclerosi Multipla (FISM) to V.C. (grant 2015/R/8) and in part by National Institutes of Health (P01095467 and GM38765) to C.N.S, by Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN grant 2010–2011) to M.M., and by Ministero della Salute (RF-2011- 02346771) and FISM (grant 2013/R/2) to L.B.en_US
dc.language.isoenen_US
dc.publisherAmerican Association for the Advancement of Scienceen_US
dc.relation.ispartofScience Translational Medicineen_US
dc.rightsThis is the author’s version of the work. It is posted here by permission of the AAAS for personaluse, not for redistribution. The definitive version was published in Science Translational Medicine on 24 Aug 2016: Vol. 8, Issue 353, pp. 353ra111, DOI: 10.1126/scitranslmed.aaf7483
dc.titleProresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responsesen_US
dc.typeArticle
dc.rights.holder(c) The Authors, 2016
dc.identifier.doi10.1126/scitranslmed.aaf7483en_US
pubs.issue353en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttp://stm.sciencemag.org/content/8/353/353ra111.full.pdf+htmlen_US
pubs.volume8en_US
dcterms.dateAccepted2016-08-24en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record